BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15706467)

  • 1. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 2. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
    Munro J; Matthiasson P; Osborne S; Travis M; Purcell S; Cobb AM; Launer M; Beer MD; Kerwin R
    Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 4. Amisulpride augmentation of clozapine in refractory schizophrenia.
    Chiu HW; Ku YC; Li TC; Huang HT
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E15. PubMed ID: 21948906
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine with amisulpride for refractory schizophrenia.
    Agelink MW; Kavuk I; Ak I
    Am J Psychiatry; 2004 May; 161(5):924-5. PubMed ID: 15121665
    [No Abstract]   [Full Text] [Related]  

  • 6. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
    George S; Cowan C
    Acta Psychiatr Scand; 2005 Feb; 111(2):163. PubMed ID: 15667440
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine augmented with amisulpride in 3 cases of treatment-resistant early- and very early-onset schizophrenia.
    Tufan AE; Yalug I
    J Clin Psychopharmacol; 2013 Aug; 33(4):572-4. PubMed ID: 23764685
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine augmentation with amisulpride.
    Porcelli S; Serretti A; Bianchini O
    J Psychiatry Neurosci; 2014 Nov; 39(6):E38-9. PubMed ID: 25340724
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy.
    Englisch S; Enning F; Grosshans M; Marquardt L; Waltereit R; Zink M
    Clin Neuropharmacol; 2010; 33(5):227-9. PubMed ID: 20838213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.
    Hotham JE; Simpson PJ; Brooman-White RS; Basu A; Ross CC; Humphreys SA; Larkin F; Gupta N; Das M
    CNS Spectr; 2014 Oct; 19(5):403-10. PubMed ID: 24284256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
    Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
    Zink M; Mase E; Dressing H
    Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 19. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
    Lang UE; Willbring M; von Golitschek R; Schmeisser A; Matschke K; Malte Tugtekin S
    J Psychopharmacol; 2008 Jul; 22(5):576-80. PubMed ID: 18308817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical issues with amisulpride in the management of patients with schizophrenia.
    Pani L; Villagrán JM; Kontaxakis VP; Alptekin K
    Clin Drug Investig; 2008; 28(8):465-77. PubMed ID: 18598092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.